Skip to content
Independent analysis of NHS open data
PharmaInsight

Betamethasone/Doxycycline/Nystatin

Ear, Nose and Oropharynx Drugs acting on the oropharynx BNF 1203010W0
Data updated May 2026 Download CSV

Betamethasone/Doxycycline/Nystatin was ranked 1792nd of 1,792 medicines by items in May 2026, with 2 items, little changed on a year earlier.

2items 0%

Dispensed in May 2026

13items

Rolling 12 months

£652

Net ingredient cost · May 2026

Figure 1. Betamethasone/Doxycycline/Nystatin: national items dispensed by month

0 1.5 3 Apr 2023 Oct 2023 Oct 2024 Mar 2025 Jun 2025 Dec 2025 May 2026 2 Apr 2023: 1 Jun 2023: 1 Sep 2023: 1 Oct 2023: 1 Mar 2024: 2 Jul 2024: 2 Oct 2024: 1 Jan 2025: 1 Feb 2025: 3 Mar 2025: 1 Apr 2025: 2 May 2025: 2 Jun 2025: 1 Sep 2025: 1 Nov 2025: 3 Dec 2025: 2 Jan 2026: 2 Mar 2026: 1 Apr 2026: 1 May 2026: 2

Source: NHSBSA Prescription Cost Analysis, to May 2026

Download CSV
Embed this chart

At a glance

  • Therapeutic class Drugs acting on the oropharynx
  • Presentations 1 shown
  • Average cost / item £325.81
  • Year on year Little changed on a year earlier
What this is
Net ingredient cost is the list price before discounts and dispensing fees, not what the NHS finally pays.

Top presentations, May 2026

The individual products dispensed under Betamethasone/Doxycycline/Nystatin this month.

Presentations of Betamethasone/Doxycycline/Nystatin, May 2026
Presentation BNF code Items Net ingredient cost
Betamethasone 0.05%/Doxycycline 10%/Nystatin 2% m/wash sach 1203010W0AAAAAA 2 £652

Source: NHSBSA Prescription Cost Analysis · to May 2026 OGL v3.0

Compare Betamethasone/Doxycycline/Nystatin with

Other medicines in the same BNF section, by prescribing volume.